Effect of synbiotics on uremic toxins in hemodialysis patients - before-after study

Goda Tomohito0 个研究点目标入组 40 人开始时间: 2023年8月14日最近更新: 2023年11月20日

适应症

试验速览

暂无简介。

•1) Maintenance hemodialysis patients who are outpatients at the time of informed consent
•2) Patients who introduced hemodialysis more than 6 months after consent was obtained
•3) Patients who can self-medicate
•4) Patients who are 18 years of age or older, have the ability to consent, and are able to obtain written consent of their own free will.

•1) Patients with dementia
•2) Patients with inflammatory bowel disease, history of lower gastrointestinal surgery, marked ascites due to liver disease, active malignant tumor
•3) Patients who cannot stop taking other probiotics and synbiotic preparations, including supplements, from 2 weeks before the start of study drug administration until the end of the study
•4) Patients who cannot stop taking Lubiprostone, Linaclotide, and Elobixibat and general antiflatulent drugs from 2 weeks before the start of study drug administration until the end of the study
•5) Patients taking many sleeping pills
•6) Patients who are allergic to potatoes, corn, Lactobacillus/Bifidobacterium beverages/foods, and dairy products
•7) Women who are pregnant, may become pregnant, or are breastfeeding
•8) Patients with other conditions that the investigators judge to be inappropriate for the study

发起方

Goda Tomohito